FIELD: biology.
SUBSTANCE: group of inventions relates to the Bifidobacterium longum IM55 KCCM11961P strain and to use thereof. Proposed is a Bifidobacterium longum IM55 KCCM11961P strain inducingly active towards the IL-10 expression. A live cell of the Bifidobacterium longum IM55 KCCM11961P strain, a non-living cell of the Bifidobacterium longum IM55 KCCM11961P strain or a product of cultivation of the Bifidobacterium longum IM55 KCCM11961P strain, wherein the product of cultivation includes the described strain, can be used in a pharmaceutical and food composition. Also proposed is a method of prevention or treatment of allergic diseases caused by a type 1 hypersensitivity reaction comprising a stage of administering Bifidobacterium longum IM55 KCCM11961P to an individual.
EFFECT: due to an immunoregulatory effect and an inflammatory reaction inhibiting effect said strain can be effectively applied in prevention or treatment of allergic diseases caused by a type 1 hypersensitivity reaction, inflammatory diseases, immunopathological diseases, and in obtaining a medicinal product for prevention or treatment of allergic diseases caused by a type 1 hypersensitivity reaction.
18 cl, 30 dwg, 19 tbl, 11 ex
Authors
Dates
2021-07-23—Published
2018-01-31—Filed